Transition-metal-free [3 + 3] annulation of indol-2-ylmethyl carbanions to nitroarenes. A novel synthesis of indolo[3,2-b]quinolines (quindolines)

  1. ORCID Logo and
  2. ORCID Logo
Institute of Organic Chemistry, Polish Academy of Sciences, Kasprzaka 44/52, 01-224 Warsaw, Poland
  1. Corresponding author email
Associate Editor: J. Aubé
Beilstein J. Org. Chem. 2018, 14, 194–202.
Received 03 Oct 2017, Accepted 10 Jan 2018, Published 23 Jan 2018
Full Research Paper
cc by logo


Indol-2-ylmethyl carbanions stabilized by alkoxycarbonyl, cyano or benzenesulfonyl groups react with nitroarenes to form σH-adducts, which in the presence of base (triethylamine or DBU) and trimethylchlorosilane transform into indolo[3,2-b]quinoline derivatives in moderate to good yields.


The indolo[3,2-b]quinoline (quindoline) system is present in numerous alkaloids of plant origin representing several biological activities and used in traditional tropical medicine for the treatment of various diseases, particularly malaria [1-5]. Further development revealed the potential of synthetic quindoline derivatives as anticancer agents [1,6,7] (Figure 1).


Figure 1: Selected indolo[3,2-b]quinolines (quindolines) with biological activity.

Synthetic strategies towards indolo[3,2-b]quinolines have been reviewed [8]. These methodologies usually employ multistep procedures. Selected starting materials applicable to the synthesis of indolo[3,2-b]quinolines are presented in Scheme 1.


Scheme 1: Selected starting materials for the construction of the quindoline system.

Bis(2-nitrobenzyl)malonate upon treatment with sodium hydroxide undergoes a multistep transformation resulting in 11-hydroxyindolo[3,2-b]quinoline-5-N-oxide (a) [9]. This approach is based on the first synthesis of the indolo[3,2-b]quinoline framework by Fichter and Boehringer in 1906 [10]. Indoxyl [11] and N,O-diacetylindoxyl [12] under basic conditions condensed with isatine to form quindoline-11-carboxylic acid easily transformed into quindoline (b) [12]. Another application of indole derivatives to the construction of quindoline starts with the reaction of 1-phenylsulfonylindole with 2-nitrobenzaldehyde (c) [13]. Several methods use prerequisite quinoline derivatives for the construction of the pyrrole ring of quindoline. 2-(2-Aminophenyl)-3-bromoquinoline cyclized to quindoline by reacting with pyridinium hydrochloride (d) [14]. Insertion of nitrene generated from 2-(2-nitrophenyl)quinoline by triethylphosphite (e) [15] and palladium(II) acetate-mediated oxidative cyclization of 3-(phenylamino)quinoline (f) afford quindoline [16]. Some of these syntheses require harsh conditions and multistep procedures. Another drawback of some of the known methodologies is the use of transition metal catalysts for the formation of prerequisite reagents or for ultimate steps of the synthesis resulting in the formation of the indolo[3,2-b]quinoline framework [14,16-18]. These procedures may require meticulous removal of traces of transition metals, particularly if the product is intended to use in biomedical or pharmaceutical applications [19].

During our studies on the reactions of nitroarenes with nucleophiles [20-23], particularly carbanions, we were interested in a direct transformation of the formed σH-adducts into heterocyclic systems – indoles [21,23] and quinolines [21,22]. Quinolines were formed when the σH-adducts, obtained from an allyl sulfone carbanion, were treated with a silylating agent or a Lewis acid [24]. In a similar reaction σH-adducts of benzyl carbanions of arylacetonitriles upon treatment with trialkylchlorosilanes yielded 9-cyanoacridines [25]. This [3 + 3] annulation leading to quinoline can be considered as an umpolung of the Skraup quinoline synthesis since it uses reversed polarity of reagents, where the C=C–NO2 fragment of the nitroarene is the electrophile reacting with an arylmethyl carbanion, the nucleophile (Scheme 2). Recently, we used the reactions of heteroanalogues of benzyl carbanions to synthesise 11-substituted norcryptotackieine derivatives (indolo[2,3-b]quinolines) [26], benzothieno[2,3-b]quinolines [27], and other tetra- and pentacyclic polyazaarenes containing the quinoline system [28].


Scheme 2: Synthesis of condensed pyridines mediated by a σH-adduct.

We elaborated two general variations of this methodology. In the first one, both reagents, C–H acid and nitroarene, upon treatment with a relatively weak base such as DBU and a silylating agent or Lewis acid, undergo slow transformation to the quinoline derivative. In this process, a low concentration of the σH-adduct is postulated. Another approach uses a strong base such as potassium tert-butoxide to form the σH-adduct in high concentration. This σH-adduct is then treated with a silylating agent and a weaker base to form the final product.

Results and Discussion

In this paper, we present the transformation of σH-adducts, formed from indol-2-ylmethyl carbanions and nitroarenes, to indolo[3,2-b]quinoline derivatives. As starting nucleophile precursors, we have chosen derivatives of indole-2-ylmethyl phenyl sulfone (1a), tert-butyl indol-2-ylacetate (1b,c) and indol-2-ylacetonitrile (1d).

As a model compound for screening of the reaction conditions, we used sulfone 1a. We found that no reaction occurred when the sulfone and 4-chloronitrobenzene were treated with DBU and trimethylchlorosilane. Even when we kept these reagents for a prolonged time (up to six days) no product was observed and the starting materials were recovered. When we treated these reagents in tetrahydrofuran solution containing triethylamine precooled to −70 ºC with t-BuOK and after 20 min added trimethylchlorosilane, stirred for 3 h at −65 to −60 °C, and then allowed to reach room temperature and stirred for 24 h we obtained 10-(n-butyl)-11-benzenesulfonyl-10H-indolo[3,2-b]quinoline 3 in 59% yield.

Under these conditions other nitrobenzene derivatives 2a–e reacted similarly, giving the condensed azaarenes (4–9) in good yields. The results are summarized in Table 1.

Table 1: The synthesis of indolo[3,2-b]quinolines (step-by-step procedure).

[Graphic 1]
Indole ArNO2 Product Yield (%)
1a 2a [Graphic 2]
1a 2b [Graphic 3]
1a 2c [Graphic 4]
1a 2d [Graphic 5]
1a 2e [Graphic 6]
1b 2a [Graphic 7]
1b 2b [Graphic 8]

In some cases, we observed in the reaction of sulfone 1a the formation of other products. This occurred in the reaction with 2,4-dichloronitrobenzene (2f), where we obtained 3-(indol-2-yl)-2,1-benzisoxazole 10 instead of the expected indoloquinoline. In an analogous reaction with 1-nitronaphthalene (2g) condensed isoxazole derivative 11 was formed (Scheme 3). The formation of 2,1-benzisoxazoles in reactions of benzyl sulfone carbanions with nitroarenes under similar conditions has been already observed [29].


Scheme 3: Formation of condensed isoxazole derivatives.

Reactions of tert-butyl 1-(tert-butoxycarbonyl)indol-2-ylacetate (1b) with p-chloro- and p-bromonitrobenzene led to the expected products 8 and 9 in moderate yields.

In one of our previous papers [28] we used N-silylated indol-3-ylacetonitrile as a carbanion precursor in the reaction with nitroarenes. Attempts to obtain tert-butyl N-trimethylsilylindol-2-ylacetate via direct silylation of the ester 1c with trimethylchlorosilane was unsuccessful, the product proved unstable and decomposed rapidly. Thus, we decided to perform a one-pot reaction in which in situ N-silylation furnished the expected carbanion precursor. Thus, when we treated tert-butyl indol-2-ylacetate (1c) and p-chloronitrobenzene (2a) with triethylamine and potassium tert-butoxide and then added trimethylchlorosilane we obtained unprotected indoloquinoline 12 and its N-oxide 13 in 26 and 12% yields, respectively (Scheme 4).


Scheme 4: Reaction of unprotected indole ester 1c with 4-chloronitrobenzene.

To extend the scope of the reaction to more active nitroarenes, we used slightly modified reaction conditions using DBU as a base. Earlier we have found that in the reactions of bicyclic nitroarenes this base was sufficiently strong to deprotonate ethyl N-(tert-butoxycarbonyl)indol-3-ylacetate [28].

Thus, when we mixed tert-butyl N-(tert-butoxycarbonyl)indol-2-ylacetate (1b), 5-nitroquinoline (2i), trimethylchlorosilane and DBU in dimethylformamide at room temperature we found that after four days both starting materials disappeared (TLC control) and we isolated indolophenanthridine 16 in 41% yield. Other nitroarenes under analogous reaction conditions gave condensed indole derivatives as summarized in Table 2. Better yields were obtained in the reactions of 1-(tert-butoxycarbonyl)indol-2-ylacetonitrile with nitroquinolines 2i–k and 5-nitroindazole 2l. This can be attributed to a lesser sterical demand in the formation of the σH-adduct by a carbanion stabilized by the cyano group in comparison with the ester group.

Table 2: The synthesis of indolo[3,2-b]quinolines by one-pot procedure.

[Graphic 9]
Indole ArNO2 Product Solvent Time [days] Yield (%)
1b [Graphic 10]
[Graphic 11]
MeCN 11 18
1b [Graphic 12]
[Graphic 13]
MeCN 10 40
1b [Graphic 14]
[Graphic 15]
DMF 4 41
1b [Graphic 16]
[Graphic 17]
DMF 7 13
1d [Graphic 18]
[Graphic 19]
DMF 2 72
1d [Graphic 20]
[Graphic 21]
DMF 3 51
1d [Graphic 22]
[Graphic 23]
MeCN 4 61

A plausible way for the formation of indolo[3,2-b]quinolines from σH-adduct A generated from the indolylmethyl carbanion of the sulfone and 4-substituted nitrobenzenes is shown in Scheme 5. The formed σH-adduct A undergoes O-silylation and the formed silyl nitronate B is deprotonated to form intermediate C, that, after elimination of silanol, forms nitroso intermediate D. Consecutive silylation of D leads to azaxylylene E that electrocyclizes to the dihydroquinoline framework F from which, after elimination of another molecule of silanol, the final product is formed. Similar electrocyclizations of aza-ortho-xylylenes leading to condensed heterocycles are known processes [30,31].


Scheme 5: A plausible mechanism for the formation of 11-(phenylsulfonyl)indolo[3,2-b]quinolines.


We developed a simple synthesis of indolo[3,2-b]quinoline derivatives by the reaction of nitroarenes with indol-2-ylmethyl carbanions generated from easily accessible starting materials. The reactions proceed under mild conditions and the elaborated method does not employ transition metals at any stage thus might be applicable in the synthesis of pharmaceutically important intermediates.


Melting points are uncorrected. 1H and 13C NMR spectra were recorded on Bruker Avance 500 or Varian vnmr s500 (both 500 MHz for 1H and 125 MHz for 13C spectra) instruments at 298 K. Chemical shifts are expressed in parts per million (ppm) referred to TMS, coupling constants in hertz (Hz). Electron impact mass spectra (EI, 70 eV) were obtained on an AutoSpec Premier spectrometer. Electrospray mass spectra (ESI) were obtained on 4000 Q-TRAP and SYNAPT G2-S HDMS. Silica gel (Merck 60, 230–400 mesh) was used for column chromatography (CC). Toluene or hexane/ethyl acetate mixtures were used for elution. TLC analyses were performed on Merck silica lgel 60 F254 aluminum plates with hexane/ethyl acetate mixtures. All reagents and solvents were of reagent grade or purified according to standard methods before use. All reactions were run under argon atmosphere.

Reactions of protected indol-2-ylmethyl derivatives with moderately active nitroarenes (step-by-step procedure). Synthesis of 10-n-butyl-2-chloro-11-(phenylsulfonyl)-10H-indolo[3,2-b]quinoline (3). Typical procedure. Triethylamine (0.61 g, 6 mmol) was added dropwise to a solution of 1-butylindol-2-ylmethyl phenyl sulfone (1a, 0.35 g, 1 mmol) and 4-chloronitrobenzene (0.24 g, 1.5 mmol) in anhydrous THF (12 mL) and cooled to −70 °C. Then 0.85 mL of a 1.4 M solution of t-BuOK (1.2 equiv) in THF was added dropwise and the temperature was maintained below −65 °C. After 20 min of stirring of the mixture, TMSCl (0.65 g, 6 mmol) was added dropwise at this temperature. The solution was stirred for 3 h at −65 to −60 °C, then allowed to reach rt, and stirred overnight (18–21 h). The reaction mixture was quenched with H2O (5 mL) and saturated aqueous NH4Cl solution (25 mL). The mixture was extracted with EtOAc (5 × 25 mL), and the combined extract was washed with brine (50 mL), dried over Na2SO4 and evaporated. The crude product was purified by column chromatography (silica gel, toluene/hexane 1:1, then toluene, then EtOAc/toluene 1:5). Yellow solid, yield 266 mg (59%); mp 176–178 °C (EtOAc/hexane); IR (KBr): 3052, 2958, 2900, 2874, 2855, 1971, 1936, 1903, 1820, 1780, 1736, 1618, 1578, 1547, 1496, 1480, 1460, 1444, 1424, 1408, 1382, 1366, 1332, 1320, 1302, 1221 cm−1; 1H NMR (500 MHz, CDCl3) δ 0.78 (t, J = 7.4 Hz, 3H), 1.06 (sex, J = 7.5 Hz, 2H), 1.63 (quin, J = 7.7 Hz, 2H), 4.69 (t, J = 7.8 Hz, 2H), 7.40–7.46 (m, 3H), 7.50–7.56 (m, 3H), 7.71 (td, J = 7.7, 0.9 Hz, 1H), 7.78 (d, J = 7.6 Hz, 2H), 8.19 (d, J = 8.9 Hz, 1H), 8.47 (d, J = 7.6 Hz, 1H), 8.64 (d, J = 2.1 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 13.62, 19.95, 30.20, 49.60, 111.55, 119.20, 122.04, 122.07, 122.21, 123,17, 123.55, 126.09, 127.46, 129.17, 131.06, 131.26, 133.03, 133.13, 133.30, 141.92, 143.59, 147.24, 150.26; EIMS m/z (%): 450 (31), 229 (22), 448 (73), 405 (18), 357 (12), 345 (13), 343 (12), 342 (13), 341 (37), 340 (12), 339 (12), 309 (15), 308 (21), 307 (65), 306 (62), 305 (74), 293 (17), 292 (10), 291 (10), 278 (10), 267 (42), 266 (23), 265 (100), 251 (13), 229 (13), 224 (11), 216 (11), 215 (19), 101 (30), 91 (10), 85 (17), 83 (16), 77 (19), 72 (15), 71 (22), 69 (11), 57 (39), 56 (11), 55 (44), 43.5 (34), 41.5 (28), 39.5 (11); HRMS (EI) m/z: calcd for C25H21N2O2S35Cl*+, 448.1012; found, 448.1015.

Reactions of N-Boc protected indol-2-ylmethyl derivatives with active nitroarenes (one-pot procedure). Typical procedure. Synthesis of 5,6-di(tert-butoxycarbonyl)indolo[2,3-b][1,7]naphthiridine (15). 3-Nitropyridine (0.15 g, 1.2 mmol) and tert-butyl 1-(tert-butoxycarbonyl)indol-2-ylacetate (1b, 0.33 g, 1 mmol) were dissolved in 5 mL of MeCN. The resulted mixture was stirred at room temperature until dissolution, then were added TMSCl (0.65 g, 6 mmol) in one portion and DBU (0.91 g, 6 equiv) dropwise (during 1 min). The reaction vial was stoppered and the mixture stayed without stirring at room temperature. Progress of the reaction was examined by tlc. After completion of the reaction the mixture was poured onto saturated aqueous NH4Cl solution (30 mL), extracted with EtOAc (5 × 25 mL), the combined extract was washed with brine (50 mL), dried over Na2SO4 and evaporated. The crude product was purified by column chromatography (silica gel, EtOAc/toluene: 1:10, then 1:5, then 1:2). Yellow solid, yield 167 mg (40%); mp 168–170 °C (EtOAc/hexane; then washed with pentane); IR (KBr): 3032, 3005, 2974, 2933, 2909, 2877, 1739 (CO), 1725 (CO), 1620, 1592, 1572, 1484, 1461, 1387, 1369, 1343, 1311, 1294, 1242, 1208 cm−1; 1H NMR (500 MHz, CDCl3) δ 1.77 (s, 9H), 1.78 (s, 9H), 7.50 (t, J = 7.5 Hz, 1H), 7.67 (td, J = 7.8, 1.1 Hz, 1H), 8.11–8.15 (m, 2H), 8.47 (d, J = 7.6 Hz, 1H), 8.65 (d, J = 5.8 Hz, 1H), 9.66 (s, 1H); 13C NMR (125 MHz, CDCl3) δ 28.40, 28.56, 83.97, 85.66, 116.31, 117.53, 121.99, 123.55, 124.35, 124.38, 127.16, 128.99, 131.53, 140.73, 142.28, 143.37, 149.70, 150.50, 154.09, 163.93. HRMS (ESI) m/z: calcd for C24H26N3O4+, 420.1923.; found, 420.1917.

Supporting Information

Supporting Information File 1: Experimental part and copies of NMR spectra.
Format: PDF Size: 3.9 MB Download


This work was financially supported by National Scientific Center grant No 2012/07/B/ST5/00813.


  1. Lavrado, J.; Moreira, R.; Paulo, A. Curr. Med. Chem. 2010, 17, 2348–2370. doi:10.2174/092986710791698521
    Return to citation in text: [1] [2]
  2. Dwuma-Badu, D.; Ayim, J. S. K.; Fiagbe, N. I. Y.; Knapp, J. E.; Schiff, P. L., Jr.; Slatkin, D. J. J. Pharm. Sci. 1978, 67, 433–434. doi:10.1002/jps.2600670350
    Return to citation in text: [1]
  3. Cimanga, K.; De Bruyne, T.; Pieters, L.; Claeys, M.; Vlietinck, A. Tetrahedron Lett. 1996, 37, 1703–1706. doi:10.1016/0040-4039(96)00112-8
    Return to citation in text: [1]
  4. Paulo, A.; Figueiras, M.; Machado, M.; Charneira, C.; Lavrado, J.; Santos, S. A.; Lopes, D.; Gut, J.; Rosenthal, P. J.; Nogueira, F.; Moreira, R. J. Med. Chem. 2014, 57, 3295–3313. doi:10.1021/jm500075d
    Return to citation in text: [1]
  5. Subbaraju, G. V.; Kavitha, J.; Rajasekhar, D.; Jimenez, J. I. J. Nat. Prod. 2004, 67, 461–462. doi:10.1021/np030392y
    Return to citation in text: [1]
  6. Ou, T.-M.; Lu, Y.-J.; Zhang, C.; Huang, Z.-S.; Wang, X.-D.; Tan, J.-H.; Chen, Y.; Ma, D.-L.; Wong, K.-Y.; Tang, J. C.-O.; Chan, A. S.-C.; Gu, L.-Q. J. Med. Chem. 2007, 50, 1465–1474. doi:10.1021/jm0610088
    Return to citation in text: [1]
  7. Le Sann, C.; Huddleston, J.; Mann, J. Tetrahedron 2007, 63, 12903–12911. doi:10.1016/j.tet.2007.10.045
    Return to citation in text: [1]
  8. Lavrado, J.; Moreira, R.; Paulo, A. Synthetic strategies towards bioactive indolo[3,2-b]quinolines. In Heterocyclic Targets in Advanced Organic Synthesis; do Carmo Carreiras, M.; Marco-Contelles, J., Eds.; Research Signpost: Trivandrum, 2011; pp 109–124.
    Return to citation in text: [1]
  9. Gorlitzer, K.; Ventzke-Neu, K. Pharmazie 1997, 52, 919–926.
    Return to citation in text: [1]
  10. Fichter, F.; Boehringer, R. Ber. Dtsch. Chem. Ges. 1906, 39, 3932–3942. doi:10.1002/cber.19060390475
    Return to citation in text: [1]
  11. Armit, J. W.; Robinson, R. J. Chem. Soc., Trans. 1922, 121, 827–839. doi:10.1039/CT9222100827
    Return to citation in text: [1]
  12. Holt, S. J.; Petrow, V. J. Chem. Soc. 1948, 922–924. doi:10.1039/jr9480000922
    Return to citation in text: [1] [2]
  13. Cooper, M. M.; Lovell, J. M.; Joule, J. A. Tetrahedron Lett. 1996, 37, 4283–4286. doi:10.1016/0040-4039(96)00818-0
    Return to citation in text: [1]
  14. Csányi, D.; Timári, G.; Hajós, G. Synth. Commun. 1999, 29, 3959–3969. doi:10.1080/00397919908085916
    Return to citation in text: [1] [2]
  15. Dutta, B.; Some, S.; Ray, J. K. Tetrahedron Lett. 2006, 47, 377–379. doi:10.1016/j.tetlet.2005.11.007
    Return to citation in text: [1]
  16. Ablordeppey, S. Y.; Fan, P.; Clark, A. M.; Nimrod, A. Bioorg. Med. Chem. 1999, 7, 343–349. doi:10.1016/S0968-0896(98)00244-2
    Return to citation in text: [1] [2]
  17. Fan, P.; Ablordeppey, S. Y. J. Heterocycl. Chem. 1997, 34, 1789–1794. doi:10.1002/jhet.5570340624
    Return to citation in text: [1]
  18. Arzel, E.; Rocca, P.; Marsais, F.; Godard, A.; Quéguiner, G. Tetrahedron Lett. 1998, 39, 6465–6466. doi:10.1016/S0040-4039(98)01386-0
    Return to citation in text: [1]
  19. Garrett, C. E.; Prasad, K. Adv. Synth. Catal. 2004, 346, 889–900. doi:10.1002/adsc.200404071
    Return to citation in text: [1]
  20. Mąkosza, M.; Wojciechowski, K. Chem. Rev. 2004, 104, 2631–2666. doi:10.1021/cr020086+
    Return to citation in text: [1]
  21. Mąkosza, M.; Wojciechowski, K. Heterocycles 2014, 88, 75–101. doi:10.3987/REV-13-SR(S)1
    Return to citation in text: [1] [2] [3]
  22. Mąkosza, M.; Wojciechowski, K. Top. Heterocycl. Chem. 2013, 37, 51–105. doi:10.1007/7081_2013_115
    Return to citation in text: [1] [2]
  23. Mąkosza, M.; Wojciechowski, K. Chem. Heterocycl. Compd. 2015, 51, 210–222. doi:10.1007/s10593-015-1687-4
    Return to citation in text: [1] [2]
  24. Anczkiewicz, K.; Królikiewicz, M.; Wróbel, Z.; Wojciechowski, K. Tetrahedron 2015, 71, 3924–3931. doi:10.1016/j.tet.2015.04.034
    Return to citation in text: [1]
  25. Bobin, M.; Kwast, A.; Wróbel, Z. Tetrahedron 2007, 63, 11048–11054. doi:10.1016/j.tet.2007.08.042
    Return to citation in text: [1]
  26. Nowacki, M.; Wojciechowski, K. RSC Adv. 2015, 5, 94296–94303. doi:10.1039/C5RA18626A
    Return to citation in text: [1]
  27. Nowacki, M.; Wojciechowski, K. Synthesis 2017, 49, 3794–3800. doi:10.1055/s-0036-1588426
    Return to citation in text: [1]
  28. Nowacki, M.; Wojciechowski, K. ChemistrySelect 2016, 1, 4886–4890. doi:10.1002/slct.201601128
    Return to citation in text: [1] [2] [3]
  29. Więcław, M.; Bobin, M.; Kwast, A.; Bujok, R.; Wróbel, Z.; Wojciechowski, K. Mol. Diversity 2015, 19, 807–816. doi:10.1007/s11030-015-9627-x
    Return to citation in text: [1]
  30. Wojciechowski, K. Eur. J. Org. Chem. 2001, 3587–3605. doi:10.1002/1099-0690(200110)2001:19<3587::AID-EJOC3587>3.0.CO;2-5
    Return to citation in text: [1]
  31. Elferink, V. H. M.; Bos, H. J. T. J. Chem. Soc., Chem. Commun. 1985, 882–883. doi:10.1039/c39850000882
    Return to citation in text: [1]
Other Beilstein-Institut Open Science Activities